Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05221320
Title Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors BioMed Valley Discoveries, Inc
Indications

Klatskin's tumor

intrahepatic cholangiocarcinoma

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

colorectal adenocarcinoma

pancreatic adenocarcinoma

cholangiocarcinoma

esophagus squamous cell carcinoma

gastric adenocarcinoma

Therapies

Hydroxychloroquine + Ulixertinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST